Intellia Therapeutics, Inc.

NTLA · Healthcare · $1.7B

Pre-market $12.10+0.33%

Price

$17.56

$12.03

Jul 2, 26Sep 29, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$10M+33.6%

6/'26 vs prev quarter

Company Health

Market Cap$1.7B

Cash on Hand$438M26.0% of market cap

Free Cash Flow$-264M-15.7% of market cap

Among 327 Biotechnology peers

LowMedianHigh

PSR28.3xmedian 11.4xPBR2.3xmedian 2.0xROE-55.0%median -54.5%